PerkinElmer's Mass Specs to Enable Netherlands to Expand Neonatal Screening | GenomeWeb
NEW YORK (GenomeWeb News) — PerkinElmer today said its neonatal screening technology will help expand a screening program in The Netherlands.
 
The company said it will provide four tandem mass spec systems, reagents, and software to support the nation’s five hospital screening centers.
 
The partnership will enable the country to screen for 14 disorders compared with three disorders.
Financial terms of the alliance were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.